NCT07733518

Brief Summary

The aim of this randomized controlled trial is to find the effects of eccentric and low-load blood flow restriction training on neuromuscular adaptations, muscle strength, functional performance, and disability in patients with knee osteoarthritis

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jul 2026Dec 2026

Study Start

First participant enrolled

July 21, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2026

Expected
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2026

Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 24, 2026

Last Update Submit

July 24, 2026

Conditions

Keywords

Eccentric training,Low-load blood flow restriction trainingMuscle weaknessknee Osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Surface Electromyography

    The Electromyography (EMG) is an objective assessment tool used to measure the electrical activity of muscles during contraction. Motor unit recruitment will be analyzed through the amplitude of EMG signals (root mean square, RMS), reflecting the number and synchronization of active motor units during contraction. Fatigue characteristics will be assessed using changes in EMG frequency parameters (mean or median frequency), indicating alterations in muscle fiber conduction velocity and fatigue onset that will be assessed pre and post sessions.

    Baseline and 4th week

Secondary Outcomes (3)

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    4 weeks

  • Timed Up and Go (TUG)

    4 weeks

  • Heel Raise Endurance Test

    4 weeks

Study Arms (2)

Eccentric Training

EXPERIMENTAL

Eccentric Gastrocnemius Strengthening Exercises

Other: Eccentric Gastrocnemius Strengthening Exercises

Low-Load Blood Flow Restriction Training

EXPERIMENTAL

Low-Load Blood Flow Restriction Training

Other: Low-Load Blood Flow Restriction Training

Interventions

Eccentric Gastrocnemius Strengthening Exercises .1. Eccentric Heel Drop 2. leg press calf lowering 3. Eccentric Stair Descent (Frequency: 3 sets 10 reps in session 1-2). 1. Eccentric Heel Drop 2. leg press calf lowering 3. Eccentric Stair Descent (Frequency: 5 sets 15 reps in session 3-4). Total duration is 3 sessions per week for 4 consecutive weeks.

Eccentric Training

Low-load blood flow restriction training including 1-Low-intensity gastrocnemius strengthening with BFR cuff 2-Controlled exercise with intermittent vascular occlusion (inflated 50-70% for 4 weeks, 3 rep. 1. Eccentric Heel Drop 2. leg press calf lowering 3. Eccentric Stair Descent (Frequency: 3 sets 10 reps in session 1-2). 1. Eccentric Heel Drop 2. leg press calf lowering 3. Eccentric Stair Descent (Frequency: 5 sets 12 reps in session 3-4). Total duration is 3 sessions per week for 4 consecutive weeks.

Low-Load Blood Flow Restriction Training

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age group 40-70
  • Both genders male and female
  • Clinical diagnosis of knee OA (Kellgren-Lawrence grade 1-3) of the most symptomatic knee.
  • Pain stable enough to permit exercise on Numeric Pain Rating Scale 3/10.
  • Participants must demonstrate a gastrocnemius muscle strength of grade ≥3 on the Manual Muscle Testing (MMT) scale (0-5), assessed using the standard standing heel-rise position.
  • Participants must be able to ambulate independently and participate in supervised exercise.

You may not qualify if:

  • Presence of a prosthetic knee in the affected limb.
  • Inflammatory arthritis (e.g., rheumatoid arthritis) or active flare-up of OA.
  • Cardiovascular disease contraindicating exercise (e.g., unstable angina, recent MI, uncontrolled hypertension ≥160/100 mmHg).
  • Pulmonary disease that limits safe participation (e.g., severe COPD, recent exacerbation).
  • History of deep vein thrombosis (DVT), peripheral vascular disease, or bleeding/clotting disorders.
  • Current anticoagulant therapy that increases bleeding risk (unless cleared by physician).
  • Any pathology causing significant muscle weakness (e.g., neuromuscular disorders, severe neuropathy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Railway General Hospital, Rawalpindi

Rawalpindi, Punjab Province, 46000, Pakistan

Location

MeSH Terms

Conditions

OsteoarthritisMuscle WeaknessOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesMuscular DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • KINZA ANWAR, MS-OMPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

KINZA ANWAR, MS-OMPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2026

First Posted

July 29, 2026

Study Start

July 21, 2026

Primary Completion (Estimated)

December 21, 2026

Study Completion (Estimated)

December 28, 2026

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations